Table 2 |
|||
|
Characteristics of the peptides derived from joint-related structures |
|||
| Protein |
Sequence |
Positiona |
Abbreviation |
|
|
|||
| Aggrecan core protein precursor |
LSGLPSGGEVLEISV |
1,352–1,366 |
aggrecan |
| Aggrecan core protein precursor |
ISGLPSGGDDLETST |
924–938 |
aggrecan3 |
| Calpain-2 |
HAYSVTGAEEVESNG |
262–276 |
calpain |
| Fibrillin-1 precursor |
CVDTRSGNCYLDIRP |
1,526–1,540 |
fibrillin |
| Matrix metalloproteinase-1 |
GVVSHSFPATLETQE |
14–28 |
MMP-1 |
| Matrix metalloproteinase-3 |
FFYFFTGSSQLEFDP |
446–460 |
MMP-3 |
| Matrix metalloproteinase-10 |
SAFWPSLPSGLDAAY |
329–343 |
MMP-10 |
| Matrix metalloproteinase-16 |
VKEGHSPPDDVDIVI |
539–553 |
MMP-16 |
| Tenascin |
EPVSGSFTTALDGPS |
1,789–1,803 |
tenascin |
|
|
|||
|
aAmino acid numbering according to the Swiss Protein Database. All peptides fulfill the computer search criteria described by van Bilsen and colleagues [25]. |
|||
|
Kamphuis et al. Arthritis Research & Therapy 2006 8:R178 doi:10.1186/ar2088 |
|||
